Fintech PR
IDTechEx Asks, Will LCDs Be Replaced in VR
Illuminating the Future: Quantum Dots Reshaping Display Technology
Author: Dr Xiaoxi He, Research Director at IDTechEx
CAMBRIDGE, England, Sept. 22, 2023 /PRNewswire/ — The global quantum dot (QD) material market is projected to reach US$550 million by 2034. However, this remarkable figure merely scratches the surface of the potential magnitude the market of their enabled products is set to attain, especially in one of QD’s potential application markets: displays. IDTechEx has recently published its view on global QD markets and enabling technologies, with more details that can be found in “Quantum Dot Materials and Technologies 2024-2034: Trends, Markets, Applications“.
QDs were first discovered in 1980. They are semiconductor nanocrystals in the range of 2-10 nanometers (10-50 atoms) with size-tunable features. They exhibit quantum confinement effects due to their nanoscale dimensions, leading to remarkable optical and electrical characteristics. Both QD’s photoluminescent and electroluminescent features can be applied for display applications, with different levels of commercial readiness.
“QD on Edge” adoption appeared during 2013 to 2016, with QDs placed between the row of LED and the LGP. This solution is going obsolete for a few reasons, including the limitation to be used only for edge-lit displays, requiring modification of back light unit assembly, and thus difficult to scale. In addition, one of the major players, QD Vision, left the business. Quantum dot enhancement film (QDEF) was introduced to the market in 2013, and they are still the dominant QD product today, with the advantages of being applicable to both edge-lit and direct-lit display types, easy implementation adopted to existing display manufacturing processes, lower temperature and lower light flux requirements, etc. QDEF has been explored to add barrier-free and eye-safe versions into the portfolio in 2021 and 2023, respectively.
Compared with the success of QDEF, the idea of quantum dot on glass (QDOG) was not successful. Combining glass light guide plate (LGP) and QDEF, it was aiming for a thinner and simplified design. However, the higher final price, application restrictions to only edge-lit displays with glass LGP, and in-house know-how requirements to handle the glass have made them decline, with niche applications only. QD color converter (QDCC) can be applied to both OLED and micro-LED displays, with the former already commercialized in 2022. Other emerging adoption types also include “QD on Chip”, with QDs directly deposited in the LED package on the chip, as well as quantum dot light emitting diode (QLED) displays using QDs as the emissive pixels.
The emerging adoption approaches are set to revolutionize the display industry while opening up lucrative business opportunities in an expanding market. For instance, for the QDCC implementation, instead of placing QDs in a film above the LGP, QDs act as the color converters, as shown below. They offer clear advantages, such as full color with improved color gamut, high brightness, and wider view angles compared with white OLED. QDCCs for OLED and micro-LED (μLED) or on-chip type are gaining momentum, facilitated by material advancements and fabrication technique improvement, which could eventually surpass the film-type.
Additionally, this analysis recognizes QDs as the ultimate emissive material for displays, tracking efficiency and lifetime improvements while delving into persistent challenges regarding performance, lifetime, deposition/patterning, and device design.
With QDs being able to provide distinctive value propositions, they are implemented in an increasing number of displays with various formats. Currently, QD-containing displays are usually marketed as premium, when they are combined with LCD to enhance the color gamut, appearing in almost all displays with mini-LED backlight units and adopted in OLED displays to offer better color and higher luminance without size limitation.
As these existing applications continue to evolve and solidify their place in the display market, the anticipation of new products on the horizon is driving optimism. With each technological leap, QDs are redefining the boundaries of what is achievable in terms of visual quality and energy efficiency. This, in turn, pushes the market forward, promising a substantial increase in market value as QD-enabled products continue to shape the future of display technology.
IDTechEx Research has been deeply engaged in the exploration of quantum dot technologies and markets since 2013. Throughout this period, IDTechEx has maintained a steadfast commitment to staying at the forefront of the latest research advancements and market trends. This has been achieved through an extensive interview program, direct interactions with companies, and active participation in relevant conferences and events.
Furthermore, IDTechEx Research has engaged closely with many of its clients, enabling a comprehensive grasp of their requirements. This collaboration has facilitated the provision of valuable insights into both the technological landscape and the dynamics of the market. Countless clients have benefited from this engagement, receiving strategic guidance for navigating the complexities of quantum dot technology innovation and commercialization.
Drawing from over two decades of experience in the analysis of advanced electronic materials and devices, IDTechEx Research has refined its expertise in evaluating emerging technologies. This extensive history provides a vantage point from which to understand the trajectories of various technologies, encompassing both their successes and setbacks.
If you would like to learn more details about QDs properties, their existing and future applications in various fields, challenges, trends and opportunities, business landscape, and market potential, please refer to the IDTechEx report for further information: “Quantum Dot Materials and Technologies 2024-2034: Trends, Markets, Applications“.
For more information on this report, please visit www.IDTechEx.com/QD, or for the full portfolio of research available from IDTechEx please visit www.IDTechEx.com/Research.
About IDTechEx
IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact [email protected] or visit www.IDTechEx.com.
Images download:
https://www.dropbox.com/scl/fo/owlpce1auu03n5c3xzx87/h?rlkey=gmbgbzkp4vkljwfz1dezne4z0&dl=0
Media Contact:
Lucy Rogers
Sales and Marketing Administrator
[email protected]
+44(0)1223 812300
Social Media Links:
Twitter: www.twitter.com/IDTechEx
LinkedIn: www.linkedin.com/company/IDTechEx
Photo – https://mma.prnewswire.com/media/2217241/QDs_Applied_in_Displays.jpg
Logo – https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/idtechex-asks-will-lcds-be-replaced-in-vr-301934514.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News3 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News4 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development